Could tarlatamab improve outcomes for patients with #smallcelllungcancer and #brainmetastases? At #ASCO26, Dr Mountzios reviews data showing improved intracranial PFS, OS, and brain response rates with tarlatamab compared with chemotherapy. ecancer.org/en/video/129...
Dr Giannis Mountzios speaks to ecancer about the DeLLphi-304 study.
This analysis highlights the intracranial efficacy of tarlatamab, a bispecific T-cell eng
